Enclosed are the un-audited financial results for the quarter and nine months ended 31-Dec-2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.0 pts more than Nifty Microcap 250 and 2.8 pts more than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Elixir Capital Ltd reported a sharp turnaround in its Q3 FY26 consolidated performance, with total income rising to Rs 1,371.07 lakhs (vs Rs 625.71 lakhs in Q3 FY25, +119% YoY) and net profit after minority interest jumping to Rs 402.48 lakhs (vs Rs 88.36 lakhs, +355% YoY). Basic EPS for the quarter stood at Rs 6.94 versus Rs 1.52 last year. Sequentially, total income grew about 23% from Q2 FY26 (Rs 1,117.97 lakhs) and PAT rose roughly 2.4x. However, the 9-month FY26 picture is weaker, with consolidated PAT at Rs 845.86 lakhs versus Rs 1,559.59 lakhs in 9M FY25 (about 46% lower), partly due to the prior period containing a Rs 31.65 lakh exceptional gratuity provision reversal. Standalone results remain essentially dormant, with no operating income and a small Q3 loss of Rs 0.99 lakh.
The robust Q3 rebound, driven by the broking and wealth subsidiaries, signals improving momentum and could be viewed positively by investors, though the sharp 9M decline versus last year tempers the picture and reflects lumpiness in capital-market-linked earnings. Short-term stock reaction may depend on whether the Q3 strength is seen as a sustainable inflection; diluted EPs for 9M at Rs 14.58 remains healthy.